T

Tego Science Inc
KOSDAQ:191420

Watchlist Manager
Tego Science Inc
KOSDAQ:191420
Watchlist
Price: 14 060 KRW -0.35% Market Closed
Market Cap: ₩114B

Operating Margin

-55.3%
Current
Declining
by 31.8%
vs 3-y average of -23.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-55.3%
=
Operating Income
₩-3.4B
/
Revenue
₩6.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-55.3%
=
Operating Income
₩-3.4B
/
Revenue
₩6.2B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Tego Science Inc
KOSDAQ:191420
112.6B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Lower than 92% of companies in Korea
Percentile
8th
Based on 2 615 companies
8th percentile
-55.3%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Tego Science Inc
Glance View

Market Cap
114B KRW
Industry
Biotechnology

Tego Science, Inc. engages in the manufacture and sale of cell therapy products. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-11-06. is a Korea-based company mainly engaged in the research and development, manufacture and distribution of wound-healing skin cell therapy products. The Company’s products mainly consist of cell therapy products, and laboratory cultured skin models.

Intrinsic Value
7 292.64 KRW
Overvaluation 48%
Intrinsic Value
Price
T
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-55.3%
=
Operating Income
₩-3.4B
/
Revenue
₩6.2B
What is Tego Science Inc's current Operating Margin?

The current Operating Margin for Tego Science Inc is -55.3%, which is below its 3-year median of -23.5%.

How has Operating Margin changed over time?

Over the last 3 years, Tego Science Inc’s Operating Margin has decreased from 12.8% to -55.3%. During this period, it reached a low of -55.3% on Sep 30, 2025 and a high of 12.8% on Sep 30, 2022.

Back to Top